NCT04932187 2021-09-17
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3)
Ruijin Hospital
Phase 1 Unknown
Clinical Trials
1 trialsHepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi) × camrelizumab × Clear all